Join
Live feed
·
INSIDERFilingvia Quantisnow
Apellis Pharmaceuticals Inc. logo

Director Dolsten Mikael was granted 14,312 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
APLS· Apellis Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track APLS (Apellis Pharmaceuticals Inc.) and more on Quantisnow.

Director Dolsten Mikael was granted 14,312 shares (SEC Form 4) | Quantisnow